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Efect ofAI(OH)3and Mg(OH)2 Suspesion Dosage Form on the Absorption of Oral Ciprofloxacin
Aniek Setiya Budiatin, Nunik Wahyuni, Suharyono, Toetik Aryani
Departement of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya.
Potential interaction of fluroquinolone with other drugs have been established in the several reports. The
absorption of fluroquinolones were almost entirety inhibited by concomitant administration ofdi and trivalent
cations such magnesium and aluminium in the antacids were significantly decreased the absorption of
ciprofloxacin through formation of a complex. The effect ofantacid (Antasida DOEN) 1.4 ml/kg body weight doses
which containing polyvalent cation Mg(OH). and Al(OH) ,on the absorption of ciprofloxacin, were examed in
healthy rabbit. Twelve subjects were given 23 mg/ml BW ciprofloxacin alone as control. On day 8 the six subjects
were given antacid and ciprofloxacin concomitant and the other were given antacid two hours after ciprofloxacin.
The absorption parameters of ciprofloxacin were determined by spectrofluommetric method. Those parameters
were Cmax, tmax and AL/C, the administration of ciprofloxacin and antacids concomitantly result Cmax, tmax and
AUC were I.27±0.45g/ml; 110ÿ.48.99 minutes and 248.63±94.77g.minutes/ml respectively in a significant
decrease in ciprofloxacin absorption (p<0.05) and the administration of antacids two hours after ciprofloxacin
result Cmax, tmax and AUC were l.37±0.65g/ml;75±36.74 minutes and 245.09±I00.46 g.minutes/ml respectively
in a significant decrease in ciprofloxacin absorption (p<0.05). Percentages of relative bioavailability compared
with control values were 27.06±16.70%> and 8.77±6.97% for concomitant and two hours after ciprofloxacin
respectively.
Keywords: Ciprofloxacin, Mg(OH),,Al(OH),.antacid, Spectrojluorometric
INTRODUCTION
Ciprofloxacin (fig.l) is fluoroquinolone antibiotic a
broadspectrum which can against positive and negative
microorganism as synthetic antibiotic and bactericid
especially negative microorganism P. aeruginosa (Me
Evoy, 2002). Ciprofloxacin were used for treatment
desease: GIT, respiratory tract up and down; urinary tract,
skin infection, which inhibit enzim topoisomcrase II sub
unit A (ADN gyrase) and topoisomerasc IV in DNA
synthesis as a potential antibacterial (Ball, 2000). Plasma
concentrations in healthy volunteers reach a mean peak
drug plasma concentrations (Cÿ,) of approximately 2.8
and 5.2mg/L within 1 to 2 hours after oral administration
of ciprofloxacin 250 and 500mg tablets, respectively. The
oral absorption is very rapid and complete, the
bioavailability of oral ciprofloxacin approaches 100%and
it little affected by administration with food (Fish and
Chow, 1997).
aluminum and magnesium containing antacid with
fluoroquinolones as ciprofloxacin, resulting in
significantly decrease absorption and bioavailability
when administered concurrently (Stockley, 2001). Nix et
al. (1989) were reseached that plasma concentrations in
healthy volunteers decreased 85% when ciprofloxacine
was gived 5 until 10 minute after antacid (Maalox*)
because ciprofloxacine and antacid formed complex
metal (Stockley, 2001). A measure such as tÿ, does not
adequately describe situations in which double peaking
may occur or which prolonged absorption are observed.
Antacid (Mg (OH), and Al(OH) ,) is widely used for a
variety of indications ( duodenal ulcer disease, dyspepsia,
saur stomach), the mechanism of antacid are neutralize
acid and stimulate mucosal defenses (Me Evoy,2002).
The probably that ciprofloxacin will be given to patients
receiving long term therapy with antacid/H2 blocker is
high. Since antacid affect oral absorption of variety of
agents, the effect of administration of antacid on the
absorption of ciprofloxacin was studied (Radanst et al.,
1992), Therefore studies were perform to determined the
effect of antacid administration on the oral absorption of
ciprofloxacin in healthy rabbits by spectrofluorometric
(El-K.ommoseta!.,2003)
HN
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F COOH MATERIALAND METHODS
Materials and reagents. Ciprofloxacin was a kind
gift of PT Kimia Farma. Methanol (HPLC gradient) was
purchased from JT Baker, antacid DOEN was a kind gift
of First Medipharma. dipotassium hydrogenphosphate
and phosphoric acid 85% were purchased from Merck
(Darmstadt, Germany), double distilled water was
obtained from PT. Ikapharmindo Putramas (Indonesia).
o
Figure 1. Ciprofloxacin
In separate study, the effect of antacid, sucralfat; food,
H2 receptor antagonis on fluoroquinolon interaction was
examined (Radanst et al., 1992). The interactions with
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One milliliter of clear supernatant was spiked with 1 ml of
drugstock solution.The mixture was then extracted with 2
portions; each of 5ml chloroform. The chloroform extract
was collected, evaporated on a boiling water bath, then
appropriate dilutions were made to obtain drug solutions
containing 100, 300 and 500ng/ml, then general
procedure was followed.
The effect of antacid. The twelve rabbits were the
same treatment as ciprofloxacin alone, and the day 8, six
rabbits were administered antacid and ciprofloxacin
concomitant and the other one were administered antacid
2 hoursafterciprofloxacin.
The pharmacokinetic analysis of plasma
concentration of ciprofloxacin were determined using
spectrofluoro metric method . The assay had a dynamic
range of 10 to 60 ng/ml (El-Kommos et al.. 2003). The
maximum plasma concentration of ciprofloxacin (Cÿ)
and earliest time at which occurred (t„„) were
estimated directly from the experimental data. The
intensity under the plasma concentration-time curve from
time zero to the last time (t) plasma ciprofloxacin was
measurable (AUQ.,,,,) was estimated by the linier
trapezoidal approximation (Shargel, 2005).
Student's t tests with 95% confidence limits were used
to examine pair-wise differences between the groups.
Value of p<0.05 were considered to be statistically
significant (Santosa et al., 2005).
Previous studies have demonstrated that the
absorption of orally administered ciprofloxacin is
impaired by concomitant administration of magnesium
and aluminum-containing antacids. This interaction may
result from the formation of ciprofloxacin - metal
complexes that poorly absorbed (Nix et al., 1989). The
mean plasma ciprofloxacin concentration-time curves for
the administered antacid and ciprofloxacin concomitant
groups were significant different (p<0.05). Cmax, tmax
and AUC were 1.27±0.45pg/ml; 1 10±48.99 minutes and
248.63±94.77jjg. minutes/ml respectively (figure 2, and
Table I as Tl) and the administered antacid two hours
after ciprofloxacin result Cmax, tmax and AUC were 1.37
±0.65pg/ml; 75±36.74 minutes and 245.09±100.46pg.
minutes/ml respectively in a significant decreased in
ciprofloxacin absorption (p<0.05). Percentagesof relative
bioavailability compared with control values were 27.06±
16.70% and 8.77±6.97% for concomitant and antacid two
hoursafterciprofloxacin respectively.(Figure 3,andTable
Heparin 500unit/ml, ammonium molybdat were
purchased from Fluka AG, citric acid was purchased from
Riedel-de Haen, xylol was obtained from Brataco
Chemika, Acetonitril was purchased from Riedel-de
Haen,
Apparatus. Hitachi F-4000 Spectrofluorometer
(Japan) was used for fluorometric measurements, Direct
Reading Micro Balance LM-20 Libror, Ultrasonic
Cleaner Sakura US-10E, Centrifuge Hettich, Protofix 32,
Thermolyne Bamstead type 37600, glassware and
injection syringe.
Standard preparations. Stock solutions containing
lg/ml of each ciprofloxacin was prepared in methanol.
Workingstandard solutionscontaining 100-600ng/ml was
prepared by suitable dilution of the stock solutions with
methanol.
Sampling. The method animal was used Australian
Rabbit from Batu Malang, weight 2,5kg. Treatment
antacid 14mg/kg BW of rabbit, 70mg/ml oral solution
form and ciprofloxacin 23mg/ml kg BW of rabbits (Paget,
1964). The twelve rabbits were fast overnight before drug
administration and 2 hours after the dose was
administered. Water was allowed ad libitum 10 ml. Blood
sample (2ml) were collected with injection syringe 2.5cc
containing anticoagulant via ear of marginal venous.
Samples were collecting in a vacuum test tube. Blood
samples were obtained immediately before and 5, 10, 20,
30 ,45, 60, 75, 90, 120, 300 minutes after ingestion of the
orally administered formulation.. Plasma was harvested
and samples were stored at -20°C until assayed. Plasma
concentration of ciprofloxacin were determined by
spectrofluorometric. The assay was liniar over the
calibration range 100 to 600ng/ml (El-Kommos et all,
2003)
General procedure.One milliliter aliquot volumes of
standard or sample solutions were transferred into 10-ml
calibrated flask. One milliliter of the ammonium
molybdenum solution (7.5g/ml) was added and pH was
adjusted to 3.5 using 1 ml ofTeorell and Stenhagen buffer
solution. The volume was completed with methanol. The
relative fluorescence intensity of resulting solutions were
measured against reagent blanks treated similarly at the
excitation and emission maxima specified for
ciprofloxacin. (El-Kommosetui,2003).
Plasma treatment (El-Kommos et.al., 2003). Five
milliliter of plasma were deproteinized by the addition of
10 ml acetonitrile, centrifuged at 4000 rpm for 5 minutes. 2)
Table 1. Summary of pharmacokinetic parameter of the administrated antacid and ciprofloxacin concomitant (Tl )and
antacid 2 hoursafterciprofloxacin (T2)
Treatment I and Treatment 2Control Tl and T2Variabel
AUC 0-300minutts
(jig.minute/L)
t max (minute)
C max (pg/L)
188.23±99.83 224.35±93.92248.63±94.77 245.09±100.46
65.00±12.25
1.41±0.55
1 10±48.99
1.27±0.45
75.00±36.74
1.37±0.65
170.00±72.66
1.05±0.40
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Figure 2. Concentration (pg/ml) versus time (minutes) curve trom antacid and ciprofloxacin concomitant
Table 2. Summary of t account; t table and probability of absorption parameter
Absorption parameter t table probabilityt account
Cmax Ti 1.468 2.571 0.202
0.788T2 -0.283 2.571
AUC0-300
5.140 2.571 0.004Tl
3.313 2.571 0.021T2
T max
-1.581 2.571 0.175Tl
T2 0.598 2.571 0.576
n U60 -
§ 1.40 -
° 1,20 -9
$ l'000,80 -
0,60 -
0,40 -
* 0,20 -
3 0,00 ■
Control
Treatment
too 300 400200
time (minute)
0
Figure 2. Concentration (pg/ml) versus time (minutes) curve administered antacid 2 hours after ciprofloxacin
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RESULTSAND DISCUSSION
To determine the effect of timing on absorption of
antacid and ciprofloxacin administered of single 23mg/kg
BW dose of ciprofloxacin to 12 healthy rabbits in two-way
crossover study, ciprofloxacin was given alone or
combined with otheran magnesium/aluminum containing
antacid 14ml/kg BW; the timing of antacid and
ciprofloxacin administration was varied (concominant
and antacid 2 hours after ciprofloxacin). The literature
describing reduced absorption of fluoroquinolones due to
antacid administration to patients and volunteers is most
extensive for ciprofloxacin (Figure 4) where in the gastro
intestinal region the complex chelat form of antacid
(metal = Mg and Al) and ciprofloxacin couldn't absorbed
(Nix et al.. 1989; Brighty et al.,2000) Those parameters
were Cmax, tmax and AUC, the administration of
ciprofloxacin and antacids concomitantly result Cmax,
tmax and AUC
minutes and 248.63 ±94.77 g.minutes/ml respectively
55.29%, 53.91% significant different (p<0.05) (Santosa,
et al., 2005) respectively and t„s increased 180% but not
significant different (p>0.05) (Table 1 and figure 2).
were 1.27±0.45 g/ml; I10±48.990-300
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..IMtaaMBaccc of the antacid 2 hours after ciprofloxacin
4bck INK *j* significant different in C
_
5.74% and
I 07% ip>0.05) respectively and tm> increased
1 % 56« not significant different (p>0.05). The
of absorption can be significant and potentially
at so the failure of the treatment, even when
aprofioxacin dose are separated from antacid dose by
-rsoce than 2 hours ( Radanst et al. 1992) in a significant
decrease in ciprofloxacin absorption (p<0.05) and the
administration of antacids two hours after ciprofloxacin
result Cmax, tmax and AUC were 1,37±0.65g/ml;
75±36.74 minutes and 245.09±100.46 g.minutes/ml
respectively in a significant decrease in ciprofloxacin
absorption (p<0.05). Percentages of relative
bioavailability compared with control values were
27.06±16.70%and 8.77±6.97% forconcomitant and two
hours afterciprofloxacin respectively.
l ,Y h::x .:-bMetal. ■r•V
.1.. I,
fT
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Figure 4. Ciprofloxacin/ levofloxacin and metal complex form the reaction (Nix et al.. 1989; Brighty et al ,2000)
Conclusions. Complex form of ciprofloxacin with
Mg(OH), and AI(OH), re-precipitated in small intestine
would play an important role in the reduced
bioavailability (C max and AUC) if ciprofloxacin co¬
administration with Mg and Al-containing antacids
concomitant.
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